Definite Plaque Echolucency is Associated with a Higher Risk of Ipsilateral Ischaemic Stroke during Early Follow up in the Asymptomatic Carotid Surgery Trial-1 (ACST-1)  by Huibers, A. et al.
396 European Journal of Vascular and Endovascular Surgery Volume 50 Issue 3 p. 390e404 September/2015operatively with suturing of the graft proximally due to poor proximal
seal without endoleaks.
Conclusion: Acute bEVAR of ruptured TAAA provides good results in the
short-term suggesting it as a valid option in the acute setting.
Analysis of 100 Reported Deaths after Elective TEVAR/EVAR in 1
Year Reveals At Least Half were Preventable!
R. Gambhir, H. Slim, H. Mistry, A. Choong, D. Valenti, H. Rashid
King’s College Hospital, London, United Kingdom
Introduction:
Objective: To analyse the cause of deaths following elective TEVAR and
EVAR as reported on manufactures and user facility device experience
(MAUDE) database of US FDA and identify areas of concern.
Methods: The MUADE database was searched for deaths associated
with the use of Aortic stent grafts. The search criteria used was ‘System,
Endovascular Graft, and Aortic Aneurysm’. Search was done retrospectively
from 31 Jan 2015 for 100 consecutive death reports.
Results: Six different Aortic stent graft systems had been used. There
was no report of device related death, all were procedure related with non
IFU use in over 20% of cases. 30% deaths occurred in peri-operative period
from causes like hypovolemia from aortic or iliac rupture, retrograde or
antegrade dissections, air embolism. Difﬁculty in deployment of stents or
accessories was reported in 15% and acute renal failure causing death in
25%. Open conversion was associated with death in over 90% of patients.
Delayed rupture with or without sac expansion was noted in 20% of pa-
tients. No cause of death was identiﬁed in 10% of patients.
Conclusion:Deaths after elective TEVAR/EVAR are a reality that cannot be
ignored. There is a need to take ownership of the reporting systems by
physicians. Better sharing of adverse events may help prevent some of these
deaths.
Intra-operative Analysis of Motor Evoked Potentials to Evaluate
the Risk of Paraplegia during Branched EVAR for Thoraco-
abdominal Aneurysm
P.M. Kasprzak, M. Wagenschwanz, B. Cucuruz, W. Mess, R. Kopp
Department of Vascular and Endovascular Surgery, University Hospital
Regensburg, Germany
Introduction: Spinal cord ischemia (SCI) is a major complication after aortic
repair of thoraco-abdominal aneurysms (TAAA). Recently, we introduced
the concept of temporary aneurysm sack perfusion (TASP) to prevent
paraplegia during branched EVAR for TAAA. These patients seem to have a
reduced risk for post-operative SCI, but they need a second procedure for
branch occlusion. Intra-operative assessment of the neurologic status using
motor evoked potentials (MEPs) might allow an intra-operative decision for
TASP and early or late side branch completion.
Methods: From 07/2007e01/2015, 105 patients with TAAA were
treated with branched standard or custom made endovascular stent grafts.
All patients received peri-operative spinal drainage. Temporary aneurysm
sack perfusion (TASP) was performed for SCI prevention in n ¼ 52 patients.
Intra-operative assessment of spinal cord function using MEPs was per-
formed in n ¼ 27 (26%) patients. In n ¼ 20 (19%) patients additional intra-
operative balloon occlusion of the TASP branch was performed. De-
mographic data, comorbidities, neurologic symptoms and variables related
to aneurysm or endovascular treatment were analyzed. Post-operative SCI
was deﬁned as motor deﬁciency (Tarlov 0e2) day 0e7 post-operatively and
day 30.
Results: Post-operative transitory neurologic deﬁciency was
observed in 21/105 (20%) patients and 13/105 (12%) patients had
paraplegia after 30 days. In the TASP group 3/52 (5.7 %) patients had
severe SCI after bEVAR, two of them after secondary branch occlusion.
None of these 2 patients had intra-operative MEPs monitoring. Based
on intra-operative MEPs monitoring with an additional side branch
balloon occlusion test for 45 min 7/20 patients with low risk of spinal
cord ischemia had intra-operative immediate side branch occlusion and
no paraplegia. In 13/20 patients a decrease of motor evoked potentialswas observed and these patients had TASP with secondary side branch
occlusion.
Conclusion: Neurologic monitoring during bEVAR with MEPs is feasible
and with relevant information regarding the risk of paraplegia and the
therapeutic concept including TASP.
Deﬁnite Plaque Echolucency is Associated with a Higher Risk of
Ipsilateral Ischaemic Stroke during Early Follow up in the
Asymptomatic Carotid Surgery Trial-1 (ACST-1)
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Introduction: Several carotid plaque characteristics, including a thin ﬁbrous
cap, lipid necrotic core and intraplaque haemorrhage, have been suggested
as potential markers to select patients at high risk for future stroke. On
ultrasound, these “high risk” characteristics appear echolucent. The
Asymptomatic Carotid Surgery Trial-1 (ACST-1) is the largest randomised
controlled trial comparing carotid endarterectomy (CEA) with deferral of
CEA in patients with severe asymptomatic carotid artery stenosis. We
aimed to assess whether ultrasound characterized plaque echogenicity was
a predictor for ischaemic stroke in asymptomatic patients randomized to
deferred treatment in ACST-1.
Methods: 814 patients randomized to deferred surgery who had
baseline plaque assessment conﬁdentially classiﬁed as echolucent (>25%
soft plaque) or non-echolucent (<25% soft plaque) were studied. Kaplan-
Meier survival curves were used to calculate cumulative rates of ipsilateral
ischaemic stroke in both groups.
Results: Life table analysis showed a signiﬁcantly higher 5 year risk of
ipsilateral stroke in patients with deﬁnite echolucent plaques (8.0%; 95% CI:
6.4 - 9.6) when compared to patients with deﬁnitely non-echolucent plaques
(3.1%; 2.1 - 4.1) (p ¼ 0.009). After adjustments of other risk factors, plaque
echolucency was associated with a 2.5 times increased risk of ipsilateral
ischaemic stroke (HR 2.52, 95% CI: 1.20e5.25; p ¼ 0.014). The use of lipid
lowering therapy was low in both groups during the ﬁrst 5 years after
randomization but rose signiﬁcantly thereafter and during the later stages of
follow up, and was more commonly prescribed in patients with echolucent
plaques (p ¼ 0.001). The risk of ipsilateral ischaemic stroke at 10 years was
similar for both levels of echogenicity (p ¼ 0.421) as was the risk of any
stroke at 10 years (p ¼ 0.632).
Conclusion: Deﬁnite plaque echolucency (>25% soft plaque) might be a
predictor of ipsilateral stroke and is associated with a higher 5 year ipsi-
lateral stroke risk in these trial patients with asymptomatic carotid disease.
The similar stroke risk outcomes at 10 years for both groups could possibly
be explained by a higher use of lipid lowering therapy during later follow
up in patients with deﬁnite echolucent plaques.
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Introduction: Recent guidelines regarding surgical treatment of asymp-
tomatic carotid stenosis recommend exclusion of patients without a min-
imum life-expectancy of 3 e5 years. Purpose of this study is to validate a
previously derived risk scoring system to identify factors associated with a
higher mortality during long-term follow up after carotid endarterectomy
(CEA).
Methods: The factors were derived from a cohort of 648 asymptomatic
patients. According to the weight of each variable, the score system
included age (<70 ¼ 0 points, 70e79 ¼ 4 points, 80 ¼ 8 points), renal
status (creatinine 1.5 ¼ 4 points and dialysis ¼ 8 points), chronic
